Sign in

    Justin Schreiber

    Chief Executive Officer at LifeMD Inc
    Board
    Since April 1, 2022
    Age
    41 years
    Education
    Holds a BS in International Business from Elizabethtown College and a BA in International Management from the ICN École de Management in Nancy, France.
    Tenure
    Joined LFMD in 2018 where he initially served as CEO and later took on additional roles including President and Chairman of the Board.

    Also at LifeMD Inc

    DW
    Dennis Wijnker
    Chief Technology Officer (CTO)
    JF
    Jessica Friedeman
    Chief Marketing Officer
    MB
    Marc Benathen
    Chief Financial Officer (CFO)

    About

    Justin Schreiber is a seasoned executive with a diverse background in international business and healthcare consulting, having worked in currency trading and advisory roles before establishing his own ventures.

    He joined LFMD in 2018, beginning his tenure as Chief Executive Officer and subsequently taking on further responsibilities as President and Chairman of the Board, demonstrating a steady progression in leadership within the organization.

    With a strong educational foundation and extensive experience in both capital markets and investor relations, his contributions to LFMD have been pivotal as he dedicates a significant portion of his time to driving the company’s strategic initiatives.

    $LFMD Performance Under Justin Schreiber

    Past Roles

    OrganizationRoleDate RangeDetails
    LifeMD CEO and Chairman (Consulting Agreement) April 2020 - 2022 Held under a consulting agreement before formal CEO appointment
    LifeMD President 2018 - 2021
    LifeMD PR, LLC President 2017 - N/A Wholly-owned subsidiary in Puerto Rico
    LifeMD Chairman of the Board 2019 - N/A
    Private Consulting Business Investor Relations, Advisory & Capital Raising Consultant N/A [N/A]Provided consulting services to small publicly traded companies
    Global Healthcare Consulting Firm Consultant N/A [N/A]Worked in a global healthcare consulting firm
    Foreign Currency Trading Business Trader N/A [N/A]Worked in the foreign currency trading business

    External Roles

    OrganizationRoleDate RangeDetails
    JLS Ventures President and Founder Present [N/A]Investment and capital markets advisory firm that invests in emerging growth publicly traded companies

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Salary$300,000 Annual (2023)Base salary per employment agreement effective April 1, 2022.
    Bonus$225,000 Annual (2023)Performance bonus awarded for 2023.
    Stock Awards$355,000 Granted in 2023Aggregate grant date fair value of restricted stock units; includes 50,000 RSUs granted on November 13, 2023 that vest on January 1, 2024.
    Other Compensation$8,803 2023Includes company contributions to the 401(k) account.
    Long-Term Incentive Awards - Time-Based VestingN/AVesting per agreed schedule25,000 shares vested immediately on November 13, 2023; 50,000 shares vesting on January 1, 2024; 75,000 shares vesting on January 1, 2025.

    Performance Compensation

    Data from  FY 2023

    Long-Term Incentive Awards - Performance-Based Vesting

    • 75,000 restricted shares are scheduled to vest on March 1, 2024 based on 2023 performance. Specific performance metrics, thresholds, targets, or evaluation conditions are not detailed in the available documents.

    Long-Term Incentive Awards - Performance Milestones

    ComponentSharesThreshold/TargetTarget DateGrant DateAdditional Details
    $100M Performance Milestone Award100,000 $100 million net revenue with 5% adjusted EBITDA marginOn or before December 31, 2025 November 13, 2023 Restricted shares vest upon achieving the milestone; all shares vest immediately upon a Change in Control; forfeiture conditions apply in cases of misconduct.
    $150M Performance Milestone Award100,000 $150 million net revenue with 10% adjusted EBITDA marginOn or before December 31, 2026 Not explicitly stated Vesting occurs upon achievement; early vesting may occur upon termination without Cause or for Good Reason, and all shares vest immediately on a Change in Control.
    $200M Performance Milestone Award100,000 $200 million net revenue with 10% adjusted EBITDA marginOn or before December 31, 2027 November 13, 2023 Valuation reference includes a stock price of $8.29 on December 29, 2023 ; standard forfeiture provisions apply; accelerated vesting upon Change in Control.

    This table outlines the performance compensation components for 2023, including both performance‐based vesting and milestone awards with their respective targets and conditions.